Page last updated: 2024-09-02

tamibarotene and Cancer of Prostate

tamibarotene has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekimoto, H; Ishigami-Yuasa, M; Kagechika, H1
Gronemeyer, H; Kagechika, H; Lou, YR; Miettinen, S; Tuohimaa, P1

Other Studies

2 other study(ies) available for tamibarotene and Cancer of Prostate

ArticleYear
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.
    Biological & pharmaceutical bulletin, 2019, Volume: 42, Issue:3

    Topics: Antineoplastic Agents; Benzoates; Cell Line, Tumor; Decitabine; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Male; Prostatic Neoplasms; Pyridines; Receptors, Retinoic Acid; Sulfonamides; Tetrahydronaphthalenes; Vorinostat

2019
Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.
    Biochemical and biophysical research communications, 2005, Dec-30, Volume: 338, Issue:4

    Topics: Benzoates; Calcitriol; Cell Line; Cell Line, Tumor; Cells, Cultured; Dibenzazepines; Epithelial Cells; Gene Expression Regulation; Humans; Male; Prostate; Prostatic Neoplasms; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Steroid Hydroxylases; Tetrahydronaphthalenes; Transfection; Tretinoin; Vitamin D3 24-Hydroxylase

2005